Patents by Inventor Horizon Pharma USA, Inc.

Horizon Pharma USA, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAMENTS CONTAINING FAMOTIDINE AND IBUPROFEN AND ADMINISTRATION OF SAME
    Publication number: 20140066485
    Abstract: A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in admixture, is administered three times per day.
    Type: Application
    Filed: February 15, 2013
    Publication date: March 6, 2014
    Applicant: HORIZON PHARMA USA, INC.
    Inventor: Horizon Pharma USA, Inc.
  • METHODS AND MEDICAMENTS FOR ADMINISTRATION OF IBUPROFEN
    Publication number: 20140017321
    Abstract: A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.
    Type: Application
    Filed: February 4, 2013
    Publication date: January 16, 2014
    Applicant: HORIZON PHARMA USA, INC.
    Inventor: HORIZON PHARMA USA, INC.
  • PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND AN H2 RECEPTOR ANTAGONIST
    Publication number: 20130078287
    Abstract: Pharmaceutical compositions of a H2 receptor antagonist and ibuprofen are provided herein. The compositions comprise, e.g., a core and a shell separated by a barrier layer, bilayered or trilayered compositions, or liquid formulations. Also provided are methods of making the pharmaceutical compositions, and methods of treatment comprising administering the pharmaceutical compositions.
    Type: Application
    Filed: November 19, 2012
    Publication date: March 28, 2013
    Applicant: Horizon Pharma USA, Inc.
    Inventor: Horizon Pharma USA, Inc.